Cargando…

Mesenchymal stem cells suppress CaN/NFAT expression in the pulmonary arteries of rats with pulmonary hypertension

Inflammation and hyperproliferation of pulmonary artery smooth muscle cells (PASMCs) is considered the primary pathological feature of pulmonary hypertension (PH). The present study determined that mesenchymal stem cells (MSCs) suppress the expression of calcineurin (CaN) and nuclear factor of activ...

Descripción completa

Detalles Bibliográficos
Autores principales:	LIU, JUNFENG, HAN, ZHIBO, HAN, ZHONGCHAO, HE, ZHIXU
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665924/ https://www.ncbi.nlm.nih.gov/pubmed/26640533 http://dx.doi.org/10.3892/etm.2015.2722

Ejemplares similares

Mesenchymal stem cell-conditioned media suppresses inflammation-associated overproliferation of pulmonary artery smooth muscle cells in a rat model of pulmonary hypertension
por: LIU, JUNFENG, et al.
Publicado: (2016)

Mycoplasma genitalium Protein of Adhesion Suppresses T Cell Activation via CypA-CaN-NFAT Pathway
por: Luo, Dan, et al.
Publicado: (2023)

Development and investigational new drug application of mesenchymal stem/stromal cells products in China
por: Zhao, Qinjun, et al.
Publicado: (2021)

Inhibition of SOC/Ca(2+)/NFAT pathway is involved in the anti-proliferative effect of sildenafil on pulmonary artery smooth muscle cells
por: Wang, Cong, et al.
Publicado: (2009)

Inhibition of phosphodiesterase-5 suppresses calcineurin/NFAT- mediated TRPC6 expression in pulmonary artery smooth muscle cells
por: Li, Shaojun, et al.
Publicado: (2017)

Effect of bone marrow mesenchymal stem cells on experimental pulmonary arterial hypertension
por: ZHANG, ZHAO-HUA, et al.
Publicado: (2012)

Can Pulmonary Arterial Compliance Be a Prognostic Marker for Pulmonary Hypertension?
por: Wu, Yanjuan, et al.
Publicado: (2023)

Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?
por: Willis, Gareth R., et al.
Publicado: (2018)

METTL3 Promotes Endothelium-Mesenchymal Transition of Pulmonary Artery Endothelial Cells by Regulating TRPC6/Calcineurin/NFAT Signaling Pathways
por: Kong, Chunchu, et al.
Publicado: (2023)

The protective effects of PCPA against monocrotaline-induced pulmonary arterial hypertension are mediated through the downregulation of NFAT-1 and NF-κB
por: Bai, Yang, et al.
Publicado: (2017)

Hypoxia induces pulmonary fibroblast proliferation through NFAT signaling
por: Senavirathna, Lakmini Kumari, et al.
Publicado: (2018)

Pathological function of Ca(2+)-sensing receptor in pulmonary arterial hypertension
por: Yamamura, Aya
Publicado: (2014)

Role of Store-Operated Ca(2+) Entry in the Pulmonary Vascular Remodeling Occurring in Pulmonary Arterial Hypertension
por: Masson, Bastien, et al.
Publicado: (2021)

Pulmonary hypertension and pulmonary artery dissection
por: Corrêa, Ricardo de Amorim, et al.
Publicado: (2013)

MicroRNAs and mesenchymal stem cells: hope for pulmonary hypertension
por: Zhu, Zhaowei, et al.
Publicado: (2015)

Protective effect of hydrogen sulfide on monocrotaline-induced pulmonary arterial hypertension via inhibition of the endothelial mesenchymal transition
por: Zhang, Hui, et al.
Publicado: (2019)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Pulmonary Arterial Hypertension
por: Michelakis, Evangelos D., et al.
Publicado: (2007)

Pulmonary venous remodeling in COPD-pulmonary hypertension and idiopathic pulmonary arterial hypertension
por: Andersen, Kasper Hasseriis, et al.
Publicado: (2017)

Increased pulmonary artery diameter on chest computed tomography can predict borderline pulmonary hypertension
por: Lange, Tobias J., et al.
Publicado: (2013)

Galectin-3 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension
por: Li, Tangzhiming, et al.
Publicado: (2019)

The isobaric pulmonary arterial compliance in pulmonary hypertension
por: Chemla, Denis, et al.
Publicado: (2021)

Pulmonary artery enlargement in schistosomiasis associated pulmonary arterial hypertension
por: Hoette, Susana, et al.
Publicado: (2015)

Role of macrophages in pulmonary arterial hypertension
por: Zhang, Meng-Qi, et al.
Publicado: (2023)

Regulation of Ca(2+) Signaling in Pulmonary Hypertension
por: Firth, Amy L., et al.
Publicado: (2013)

Suppression of BMP signaling by PHD2 deficiency in Pulmonary Arterial hypertension
por: Liu, Bin, et al.
Publicado: (2022)

Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension
por: Joshi, Sachindra R., et al.
Publicado: (2022)

The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats
por: Lee, Hyeryon, et al.
Publicado: (2015)

Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice
por: Alencar, Allan K. N., et al.
Publicado: (2018)

Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension
por: Oh, Seyeon, et al.
Publicado: (2021)

Is pulmonary arterial hypertension associated with schistosomiasis distinct from pulmonary arterial hypertension associated with portal hypertension?
por: Graham, Brian B., et al.
Publicado: (2023)

Pulmonary vasodilators can lead to various complications in pulmonary “arterial” hypertension associated with congenital heart disease
por: Chida-Nagai, Ayako, et al.
Publicado: (2020)

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Humbert, Marc, et al.
Publicado: (2019)

Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective
por: Koudstaal, Thomas, et al.
Publicado: (2020)

Erratum: Obesity in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry
Publicado: (2021)

Erratum: Obesity in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry
Publicado: (2022)

Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors
por: Gu, Li, et al.
Publicado: (2020)

Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling
por: Cheng, Gesheng, et al.
Publicado: (2017)

Pulmonary arterial hypertension: an update
por: Hoendermis, E. S.
Publicado: (2011)

Pulmonary arterial hypertension and pregnancy
por: Terek, Demet, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_v3s49929lk8rqc8pprc44o78ch